-
Development of an Adult Adherent Allogeneic Stem Cell Product for Treatment of Parkinson's Disease
… by the FDA for Phase I studies in humans, works through multiple mechanisms of benefit, including immune modulation … neuroprotection, in pre-clinical models of central nervous system (CNS) injury and disease. Translationally relevant … administration provides documented therapeutic benefit in multiple models of CNS disease and injury, including stroke, …
-
Xenoport Announces MJFF Grant to Test Novel Compound as Potential Neuroprotective Therapy
July 11, 2012
… acid esters are also currently being tested clinically for multiple sclerosis and psoriasis (in fact, they’ve been … been shown to have adverse effects on the gastrointestinal system in previous clinical trials, but early pre-clinical …
-
Fidias Leon-Sarmiento, MD, PhD
… his current research focuses on human corticospinal (brain system) physiology (function), particularly brainstem and … numerous awards for his scientific achievements, including multiple awards from international institutions. …
-
Parkinson's Groups Support Disability Benefits for Veterans
October 19, 2016
… corticobasal degeneration, dementia with Lewy bodies, multiple system atrophy and progressive supranuclear palsy. These …
-
Proof-of-concept Study for the Development of Non-invasive Immunotherapy for Parkinson’s Disease: Intranasal Targeting of Immunoglobulin G Antibodies and Fragments to the CNS
… (PD). However, achieving reliable, chronic central nervous system (CNS) delivery for macromolecules such as antibodies … peripheral tissue levels will be measured and mapped using multiple technologies. Control experiments will be performed … to the brain of pre-clinical models and achieve levels in multiple brain areas that might be expected to have …
-
Development of a Protein Biomarker Panel to Measure Parkinson’s Disease Heterogeneity and Progression
… Octave has developed a precision-care platform for multiple sclerosis that includes a custom biomarker assay … Study Design: Octave has developed a custom assay panel for multiple sclerosis called the MS Disease Activity test. In … signatures with relevant endpoints and employing a systems biology approach to corroborating pathophysiology. …